Skip to main content
Clinical Trials/NCT00845286
NCT00845286
Completed
Not Applicable

Investigation of Myocardial Function and Vascular Adaptation in Association With Genotype in Marathon Runners

Technical University of Munich1 site in 1 country162 target enrollmentSeptember 2008

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Heart Failure
Sponsor
Technical University of Munich
Enrollment
162
Locations
1
Primary Endpoint
E/A ratio
Status
Completed
Last Updated
10 years ago

Overview

Brief Summary

The purpose of the study is to determine the myocardial function and vascular adaptation after strenuous exercise in association with genotype/polymorphisms. We aim to investigate the effects of extreme endurance exercise on the cardiovascular system. Furthermore, the role of the inflammatory response and adaptive mechanisms of the vasculature are examined. Subclinical injuries to the myocardium and vascular wall are being investigated.

Detailed Description

Regular exercise leads to an improvement of cardiovascular risc factors in patients with coronary heart disease, atherosclerosis and metabolic disorders. Aerobic exercise has anti-inflammatory effects. In contrast, the exertional exercise of marathon running causes an acute pro-inflammatory impulse. This may lead to myocardial injury and, in case of preexisting plaques, may result in plaque rupture and acute myocardial infarction. We aim to define the critical role of inflammatory markers and cardiovascular risc factors as a predictor of an increased risk for myocardial and endothelial dysfunction in marathon runners. Diagnostic tools include measurements of augmentation index (AIx), arteriolar-venular ratio (AVR) and, for the first time, 2D and 3D echocardiographic measurements such as TDI-imaging and speckle tracking. Inflammatory markers include c-reactive protein (CRP), interleukins and tumor necrosis factor. Additionally, cardiovascular markers are measured. All variations are analysed on the basis of genotype characteristics/polymorphisms.

Registry
clinicaltrials.gov
Start Date
September 2008
End Date
August 2014
Last Updated
10 years ago
Study Type
Interventional
Study Design
Single Group
Sex
Male

Investigators

Sponsor
Technical University of Munich
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • men aged 30-60 years

Exclusion Criteria

  • manifested heart disease
  • insulin dependent diabetes mellitus
  • multi drug therapy
  • GFR\<60ml/min.

Outcomes

Primary Outcomes

E/A ratio

Time Frame: pre-, post-, one day follow-up

Secondary Outcomes

  • LV twist(pre-, post-, one day follow-up)

Study Sites (1)

Loading locations...

Similar Trials